|
Volumn 131, Issue 4, 2001, Pages 457-467
|
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CIDOFOVIR;
CREATININE;
GANCICLOVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DISEASE COURSE;
DRUG IMPLANT;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
NEPHROTOXICITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RETINITIS;
TREATMENT OUTCOME;
UVEITIS;
VISUAL IMPAIRMENT;
VITREOUS HEMORRHAGE;
ADMINISTRATION, ORAL;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS RETINITIS;
CYTOSINE;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
DRUG EVALUATION;
DRUG IMPLANTS;
FEMALE;
GANCICLOVIR;
HUMANS;
INFUSIONS, PARENTERAL;
KIDNEY;
MALE;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
SURVIVAL RATE;
TREATMENT OUTCOME;
UVEITIS;
VISUAL ACUITY;
VITREOUS HEMORRHAGE;
|
EID: 0035059340
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9394(01)00840-6 Document Type: Article |
Times cited : (72)
|
References (39)
|